PDS Biotechnology Analyst Price Targets

Wall Street analyst price targets and consensus rating for PDS Biotechnology (PDSB).

Price Target Range — 11 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$9Upside to Avg. PT+733.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 8, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$7→$5
Aug 26, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$7
Aug 13, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$15→$7
Apr 15, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$15
Nov 25, 2025	B. Riley Securities	Kalpit Patel	PT Cut	Buy	$5→$3
Nov 13, 2025	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$13→$15
Jul 1, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$13
Jun 11, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$13
Mar 27, 2025	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$21→$13
Mar 13, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Mar 7, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Feb 24, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Dec 18, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Nov 25, 2024	B. Riley Securities	Kalpit Patel	PT Cut	Buy	$9→$7
Nov 15, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Oct 24, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Oct 2, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Sep 17, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21
Aug 20, 2024	Alliance Global Partners	—	PT Raise	Buy	$5→$7
Aug 1, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$21

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5

HC Wainwright & Co. analyst Joseph Pantginis maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target from $7 to $5.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $7

HC Wainwright & Co. analyst Joseph Pantginis maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target from $15 to $7.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $15 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $3

B. Riley Securities analyst Kalpit Patel maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target from $5 to $3.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Raises Price Target to $15

HC Wainwright & Co. analyst Joseph Pantginis maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and raises the price target from $13 to $15.

Benzinga Newsdesk

PDS Biotechnology Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

PDS Biotechnology Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5

PRO
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $7

PRO
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $15 Price Target

PRO
B. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $3

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Raises Price Target to $15

People Also Watch

People Also Watch

PDS Biotechnology Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

PDS Biotechnology Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5

PROHC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $7 Price Target

PROHC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $7

PROHC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $15 Price Target

PROB. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $3

PROHC Wainwright & Co. Maintains Buy on PDS Biotechnology, Raises Price Target to $15

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $5

PRO
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $7 Price Target

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Lowers Price Target to $7

PRO
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $15 Price Target

PRO
B. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $3

PRO
HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Raises Price Target to $15